US FDA approves Axsome's drug for Alzheimer's-related agitation Reuters
FDA News Release More Press Announcements The U.S. Food and Drug Administration today approved an expanded use for Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) extended-relea